glp 1 receptor agonists GLP-1 as Treatments for Type 2 Diabetes A schematic overview of GLP-1

The difference is not always body weight, and it is not always straightforward

Why Adherence Rates Differ Between Treatments Side Effects and How Patients Tolerate Them Both GLP-1 receptor agonists and metformin are known to cause gastrointestinal distress, but the way patients experience these side effects differs significantly

Tran, T

The true impact that these drugs will have on our society remains to be seen

Potential risks for those with an eating disorder include: These drugs can make recognizing (and responding) to the bodys natural hunger cues much harder, which is a major step in recovery

Your gut filters out the rest